We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$7.12B
AUM Growth
+$2.73B
Cap. Flow
-$668M
Cap. Flow %
-9.39%
Top 10 Hldgs %
41.12%
Holding
776
New
84
Increased
177
Reduced
36
Closed
54
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATH
301
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$714K 0.01%
17,578
+6
+0% +$412
SST icon
302
CALL
System1
SST
$17.5M
$711K 0.01%
+11,300
New +$985K
DCRDW
303
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
0
QBTS.WS
304
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
0
ADSEW icon
305
ADS-TEC Energy Warrant
ADSEW
0
FAZEW
306
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
0
ALTIW
307
DELISTED
AlTi Global Inc Warrant
ALTIW
0
BYND icon
308
PUT
Beyond Meat
BYND
$277M
$616K 0.01%
43,500
GWIIW
309
DELISTED
Good Works II Acquisition Corp. Warrant
GWIIW
0
ZSTK
310
ZeroStack Corp
ZSTK
$19M
$582K 0.01%
1,058
TMC icon
311
TMC The Metals Company
TMC
$1.98B
$576K 0.01%
549,808
-256,068
-32% -$247K
ZLS
312
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$559K 0.01%
+57,165
New +$559K
BZFDW icon
313
BuzzFeed Inc Warrant
BZFDW
$643K
0
TOIIW
314
DELISTED
The Oncology Institute Warrant
TOIIW
0
BKKT icon
315
Bakkt Inc
BKKT
$337M
$547K 0.01%
9,600
-6,400
-40% -$428K
PGYWW
316
Pagaya Technologies Ltd Warrants
PGYWW
$1.38M
0
NH
317
DELISTED
NantHealth, Inc
NH
$534K 0.01%
144,456
+825
+0.6% +$5.86K
FLACW
318
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
0
IVC
319
DELISTED
Invacare Corporation
IVC
$512K 0.01%
+657,278
New +$692K
GRNAW
320
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
0
CND
321
DELISTED
Concord Acquisition Corp.
CND
$503K 0.01%
50,000
-35,000
-41% -$351K
FATH.WS
322
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
0
IPOD
323
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$501K 0.01%
50,000
-1,435,032
-97% -$14.3M
LOCL.WS
324
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
0
NVAC
325
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
$499K 0.01%
+50,268
New +$498K

Similar funds

Highbridge Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Highbridge Capital Management held 776 positions worth $7.12B, up 62% from $4.39B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Highbridge Capital Management withdrew a net $668M in Q3 2022, closing 54 positions and reducing 36 holdings. Its most notable exit was Pershing Square Tontine Holdings, Ltd., an estimated $90.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 44% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Highbridge Capital Management opened a new position in Cartesian Growth Corp II worth $20.7M.

  • Highbridge Capital Management's largest Q3 2022 buy was Cartesian Growth Corp II: 2,067,942 shares worth $20.7M.
  • Highbridge Capital Management added most to Ahren Acquisition Corp in Q3 2022, an estimated $15.8M increase.
  • Highbridge Capital Management's biggest Q3 2022 reduction was Social Capital Hedosophia Holdings Corp. IV, cutting an estimated $14.3M.
  • Highbridge Capital Management fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $90.8M.
  • Highbridge Capital Management's ten largest holdings make up 41% of its $7.12B portfolio in Q3 2022.
  • Highbridge Capital Management opened 84 new positions and closed 54 in Q3 2022.
  • Highbridge Capital Management's portfolio value rose 62% quarter-over-quarter to $7.12B.

Based on Highbridge Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.